HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$2.24
Day range
$2.17 - $2.29
Year range
$0.80 - $3.42
Market cap
94.08M USD
Avg Volume
17.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.26M | -6.30% |
Net income | -2.16M | 1.93% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.35M | 637.41% |
Total assets | 10.70M | 333.60% |
Total liabilities | 963.82K | 69.32% |
Total equity | 9.74M | — |
Shares outstanding | 41.08M | — |
Price to book | 9.33 | — |
Return on assets | -49.47% | — |
Return on capital | -52.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.16M | 1.93% |
Cash from operations | -1.27M | 24.67% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.27M | 24.67% |
Free cash flow | -538.28K | 47.95% |
About
Founded
2020
Headquarters
Website
Employees
3
